Trademarkia Logo

Canada

C$
EPIXIENNE
APPROVED

on 28 Jan 2025

Last Applicant/ Owned by

Bayer Aktiengesellschaft

Kaiser-Wilhelm-Allee51373 Leverkusen

DE

Serial Number

2210060 filed on 17th Aug 2022

Correspondent Address

GOWLING WLG (CANADA) LLP

SUITE 2600, 160 ELGIN STREETOTTAWA

ONTARIO

CA

K1P1C3

EPIXIENNE

Trademark usage description

pharmaceutical preparations for the treatment of cystic diseases and disorders, not relating to skin disorders, namely, renal cystic diseases, cystic Read More

Classification Information


Class [005]
Pharmaceutical preparations for the treatment of cystic diseases and disorders, not relating to skin disorders, namely, renal cystic diseases, cystic kidney diseases, cystic lung disease, polycystic ovary syndrome, fibrocystic breast disease, ganglion cysts, and ovarian cysts; pharmaceutical preparations for the treatment of pain diseases and disorders, not relating to skin disorders, namely, chronic pain, chest pain, neurogenic pain, complex regional pain syndrome and endometriosis; pharmaceutical preparations for the treatment of inflammatory diseases and disorders, not relating to skin disorders, namely, inflammatory bowel diseases, inflammatory connective tissue diseases, inflammatory pelvic diseases, inflammatory neurogenic diseases, inflammatory muscle diseases and disorders, and arthritis; none of the aforesaid goods being hygienic preparations.


Classification kind code

11

Mark Details


Serial Number

2210060

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 48
on 9th Jan 2024
Agent Changed
Submitted for opposition 22
on 3rd Jan 2024
Search Recorded
Submitted for opposition 20
on 3rd Jan 2024
Examiner's First Report
Submitted for opposition 223
on 3rd Jan 2024
Total Provisional Refusal
Submitted for opposition 256
on 17th Jul 2023
Notification of Possible Opposition Sent
Submitted for opposition 257
on 15th Sept 2022
Designation Notification - Madrid Protocol
Submitted for opposition 1
on 14th Sept 2022
Created
Submitted for opposition 31
on 14th Sept 2022
Formalized
Submitted for opposition 30
on 17th Aug 2022
Filed
Submitted for opposition 228
on 17th Aug 2022
International Registration